Medical versus surgical interventions for the metabolic complications of obesity in children

Seminars in Pediatric Surgery

Volumn 18, Issue 3, 2009, Pages 168-175

  Dixon, John B ^a,b   Jones, Kay ^a   Dixon, Maureen ^a  

^a MONASH UNIVERSITY   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Discrimination; Insulin resistance; Metabolic; Obesity; Pediatric; Weight loss

Indexed keywords

SIBUTRAMINE; TETRAHYDROLIPSTATIN;

ARTICLE; BARIATRIC SURGERY; BODY MASS; CHILD; CLINICAL PROTOCOL; CLINICAL TRIAL; COMORBIDITY; CONSERVATIVE TREATMENT; DISEASE SEVERITY; GASTRIC BANDING; HUMAN; INFLAMMATORY DISEASE; LAPAROSCOPIC SURGERY; LIFESTYLE MODIFICATION; METABOLIC DISORDER; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUALITY OF LIFE; ROUX Y ANASTOMOSIS; STOMACH BYPASS; WEIGHT REDUCTION;

ADOLESCENT; ANTI-OBESITY AGENTS; BODY MASS INDEX; CHILD; DIET THERAPY; EVIDENCE-BASED MEDICINE; EXERCISE THERAPY; GASTROPLASTY; HUMANS; LIFE EXPECTANCY; OBESITY; OBESITY, MORBID; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 67649361543     PISSN: 10558586     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.sempedsurg.2009.04.007     Document Type: Article

References (80)

1. Ogden C.L., Carroll M.D., Curtin L.R., et al. Prevalence of overweight and obesity in the United States, 1999-2004. J Am Med Assoc 295 (2006) 1549-1555
2. Sturm R. Increases in morbid obesity in the USA: 2000-2005. Pub Health 121 (2007) 492-496
3. Troiano R.P., and Flegal K.M. Overweight children and adolescents: Description, epidemiology, and demographics. Pediatrics 101 (1998) 497-504
4. Whitaker R.C., Wright J.A., Pepe M.S., et al. Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med 337 (1997) 869-873
5. Must A. Morbidity and mortality associated with elevated body weight in children and adolescents. Am J Clin Nutr 63 (1996) 445S-447S
6. Gortmaker S.L., Must A., Perrin J.M., et al. Social and economic consequences of overweight in adolescence and young adulthood. N Engl J Med 329 (1993) 1008-1012
7. Dietz W.H. Childhood weight affects adult morbidity and mortality. J Nutr 128 (1998) 411S-414S
8. Fontaine K.R., Redden D.T., Wang C., et al. Years of life lost due to obesity. J Am Med Assoc 289 (2003) 187-193
9. Must A., Jacques P.F., Dallal G.E., et al. Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard growth study of 1922-1935. N Engl J Med 327 (1992) 1350-1355
10. Ludwig D.S. Childhood obesity: The shape of things to come. N Engl J Med 357 (2007) 2325-2327
11. Olshansky S.J., Passaro D.J., Hershow R.C., et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med 352 (2005) 1138-1145
12. Must A., and Strauss R.S. Risks and consequences of childhood and adolescent obesity. Int J Obes Relat Metab Disord 23 suppl 2 (1999) S2-S11
13. Stunkard A.J., and Wadden T.A. Psychological aspects of severe obesity. Am J Clin Nutr 55 (1992) 524S-532S
14. Puhl R., and Brownell K. Bias, discrimination, and obesity. Obes Rev 9 (2001) 788-805
15. Staffieri J.R. A study of the social stereotype of body image in children. J Pers Soc Psych 7 (1967) 101-104
16. Daniels S.R., Arnett D.K., Eckel R.H., et al. Overweight in children and adolescents: Pathophysiology, consequences, prevention, and treatment. Circulation 111 (2005) 1999-2012
17. Garcia V.F. Adolescent bariatric surgery: Treatment delayed may be treatment denied. Pediatrics 115 (2005) 822-823
18. Figueroa-Munoz J.I., Chinn S., and Rona R.J. Association between obesity and asthma in 4-11 year old children in the UK. Thorax 56 (2001) 133-137
19. Giuseffi V., Wall M., Siegel P.Z., et al. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): A case-control study. Neurology 41 (1991) 239-244
20. Loder R.T. The demographics of slipped capital femoral epiphysis. An international multicenter study. Clin Orthop 8 (1996) 8-27
21. Kershaw E.E., and Flier J.S. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89 (2004) 2548-2556
22. Boden G. Free fatty acids-the Link between obesity and insulin resistance. Endocr Pract 7 (2001) 44-51
23. Ruan H., and Lodish H.F. Regulation of insulin sensitivity by adipose tissue-derived hormones and inflammatory cytokines. Curr Opin Lipidol 15 (2004) 297-302
24. Boden G., and Shulman G.I. Free fatty acids in obesity and type 2 diabetes: Defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 32 suppl 3 (2002) 14-23
25. Lu J.Y., Huang K.C., Chang L.C., et al. Adiponectin: A biomarker of obesity-induced insulin resistance in adipose tissue and beyond. J Biomed Sci 15 (2008) 565-576
26. Rosenbloom A.L. Increasing incidence of type 2 diabetes in children and adolescents: Treatment considerations. Pædiatr Drugs 4 (2002) 209-221
27. Sorof J., and Daniels S. Obesity hypertension in children: A problem of epidemic proportions. Hypertension 40 (2002) 441-447
28. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114 (2004) 555-576
29. Din-Dzietham R., Liu Y., Bielo M.V., et al. High blood pressure trends in children and adolescents in national surveys, 1963-2002. Circulation 116 (2007) 1488-1496
30. Korsten-Reck U., Kromeyer-Hauschild K., Korsten K., et al. Frequency of secondary dyslipidemia in obese children. Vasc Health Risks Manag 4 (2008) 1089-1094
31. Lee J.M. Insulin resistance in children and adolescents. Rev Endocr Metab Disord 7 (2006) 141-147
32. Sinha R., Fisch G., Teague B., et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 346 (2002) 802-810
33. Urrutia-Rojas X., and Menchaca J. Prevalence of risk for type 2 diabetes in schoolchildren. J Sch Health 76 (2006) 189-194
34. Haines L., Wan K.C., Lynn R., et al. Rising incidence of type 2 diabetes in children in the U.K. Diab Care 30 (2007) 1097-1101
35. American Diabetes Association. Type 2 diabetes in children and adolescents. Pediatrics 105 (2000) 671-680
36. Fagot-Campagna A., Pettitt D.J., Engelgau M.M., et al. Type 2 diabetes among North American children and adolescents: An epidemiologic review and a public health perspective. J Pediatr 136 (2000) 664-672
37. Young T.K., Dean H.J., Flett B., et al. Childhood obesity in a population at high risk for type 2 diabetes. J Pediatr 136 (2000) 365-369
38. Pinhas-Hamiel O., Dolan L.M., Daniels S.R., et al. Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr 128 (1996) 608-615
39. Weiss R., Dziura J., Burgert T.S., et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350 (2004) 2362-2374
40. Newfield R.S., Dewan A.K., and Jain S. Dyslipidemia in children with type 2 diabetes vs. obesity. Pediatr Diab 9 (2008) 115-121
41. Freedman D.S., Dietz W.H., Srinivasan S.R., et al. The relation of overweight to cardiovascular risk factors among children and adolescents: The Bogalusa heart study. Pediatrics 103 (1999) 1175-1182
42. Freedman D.S., Khan L.K., Dietz W.H., et al. Relationship of childhood obesity to coronary heart disease risk factors in adulthood: The Bogalusa heart study. Pediatrics 108 (2001) 712-718
43. Cappuccio F.P., Taggart F.M., Kandala N.B., et al. Meta-analysis of short sleep duration and obesity in children and adults. Sleep 31 (2008) 619-626
44. Rudnick E.F., Walsh J.S., Hampton M.C., et al. Prevalence and ethnicity of sleep-disordered breathing and obesity in children. Otolaryngol Head Neck Surg 137 (2007) 878-882
45. O'Brien L.M., Sitha S., Baur L.A., et al. Obesity increases the risk for persisting obstructive sleep apnea after treatment in children. Int J Pediatr Otorhinolaryngol 70 (2006) 1555-1560
46. Silvestri J.M., Weese-Mayer D.E., Bass M.T., et al. Polysomnography in obese children with a history of sleep-associated breathing disorders. Pediatr Pulmonol 16 (1993) 124-129
47. Rhodes S.K., Shimoda K.C., Waid L.R., et al. Neurocognitive deficits in morbidly obese children with obstructive sleep apnea. J Pediatr 127 (1995) 741-744
48. Treadwell J.R., Sun F., and Schoelles K. Systematic review and meta-analysis of bariatric surgery for pediatric obesity. Ann Surg 248 (2008) 763-776
49. Brown W.A., Burton P.R., Anderson M., et al. Symmetrical pouch dilatation after laparoscopic adjustable gastric banding: Incidence and management. Obes Surg 18 (2008) 1104-1108
50. Inge T.H., Miyano G., Bean J., et al. Reversal of type 2 diabetes mellitus and improvements in cardiovascular risk factors after surgical weight loss in adolescents. Pediatrics 123 (2009) 214-222
51. Sjostrom C.D., Lissner L., Wedel H., et al. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: The sos intervention study. Obes Rev 7 (1999) 477-484
52. Torgerson J.S. Swedish obese subjects: Where are we now?. Int J Obes 27 (2003) 19
53. Sjostrom L., Narbro K., Sjostrom C.D., et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357 (2007) 741-752
54. Karlsson J., Taft C., Ryden A., et al. Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: The sos intervention study. Int J Obes (Lond) 31 (2007) 1248-1261
55. O'Brien P.E., Dixon J.B., Laurie C., et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: A randomized trial. Ann Intern Med 144 (2006) 625-633
56. Dixon J.B., O'Brien P.E., Playfair J., et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: A randomized controlled trial. J Am Med Assoc 299 (2008) 316-323
57. Keating C.L., Dixon J.B., Moodie M.L., et al. Cost-efficacy of surgically induced weight loss for the management of type 2 diabetes: A randomized controlled trial. Diab Care 32 (2009) 580-584
58. Keating C.L., Dixon J.B., Moodie M.L., et al. Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: Modeled lifetime analysis. Diab Care 32 (2009) 567-574
59. Taylor R. Pathogenesis of type 2 diabetes: Tracing the reverse route from cure to cause. Diabetologia 51 (2008) 1781-1789
60. Ashrafian H., le Roux C.W., Darzi A., et al. Effects of bariatric surgery on cardiovascular function. Circulation 118 (2008) 2091-2102
61. Williamson D.F., Thompson T.J., Thun M., et al. Intentional weight loss and mortality among overweight individuals with diabetes. Diab Care 23 (2000) 1499-1504
62. Knowler W.C., Barrett-Connor E., Fowler S.E., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346 (2002) 393-403
63. Tuomilehto J., Lindstrom J., Eriksson J.G., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344 (2001) 1343-1350
64. Pi-Sunyer X., Blackburn G., Brancati F.L., et al. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: One-year results of the look AHEAD trial. Diab Care 30 (2007) 1374-1383
65. Eriksson K.F., and Lindgarde F. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study. Diabetologia 34 (1991) 891-898
66. MacDonald Jr. K.G., Long S.D., Swanson M.S., et al. The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg 1 (1997) 213-220
67. Norris S.L., Zhang X., Avenell A., et al. Long-term effectiveness of lifestyle and behavioral weight loss interventions in adults with type 2 diabetes: A meta-analysis. Am J Med 117 (2004) 762-774
68. U.K. Prospective Diabetes Study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group. Diabetes 44 (1995) 1249-1258
69. UK Prospective Diabetes Study (UKPDS) Group UKPDS33. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
70. U.K. Prospective Diabetes Study Group UKPDS37. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). Diab Care 22 (1999) 1125-1136
71. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. Br Med J 317 (1998) 703-717 [Published erratum appears in Br Med J 1999;318:29]
72. Dixon J.B., Anderson M., Cameron-Smith D., et al. Sustained weight loss in obese subjects has benefits that are independent of attained weight. Obes Rev 12 (2004) 1895-1902
73. Adams T.D., Gress R.E., Smith S.C., et al. Long-term mortality after gastric bypass surgery. N Engl J Med 357 (2007) 753-761
74. Peeters A., O'Brien P.E., Laurie C., et al. Substantial intentional weight loss and mortality in the severely obese. Ann Surg 246 (2007) 1028-1033
75. Busetto L., Mirabelli D., Petroni M.L., et al. Comparative long-term mortality after laparoscopic adjustable gastric banding versus nonsurgical controls. Surg Obes Relat Dis 3 (2007) 496-502
76. Rhodes C.J. Type 2 diabetes-a matter of beta-cell life and death?. Science 307 (2005) 380-384
77. Weir G.C., and Bonner-Weir S. Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes 53 suppl 3 (2004) S16-S21
78. Wajchenberg B.L. Beta-cell failure in diabetes and preservation by clinical treatment. Endocr Rev 28 (2007) 187-218
79. Guillausseau P.J., Meas T., Virally M., et al. Abnormalities in insulin secretion in type 2 diabetes mellitus. Diab Metab 34 suppl 2 (2008) S43-S48
80. Dixon J.B. Surgical treatment for obesity and its impact on non-alcoholic steatohepatitis. Clin Liver Dis 11 (2007) 141-154